Home | | Modern Pharmacology with Clinical Applications | Calcium Channel Blockers: Toxicity

Chapter: Modern Pharmacology with Clinical Applications: Calcium Channel Blockers

Calcium Channel Blockers: Toxicity

The common side effects seen in chronic therapy (Table 19.3) are mostly related to vasodilation—headaches, dizziness, facial flushing, hypotension, and so forth.

TOXICITY

The common side effects seen in chronic therapy (Table 19.3) are mostly related to vasodilation—headaches, dizziness, facial flushing, hypotension, and so forth. High doses of verapamil in elderly patients are known to cause constipation. Serious side effects, especially fol-lowing the intravenous use of verapamil, include marked negative inotropic effects and depression of preexisting sick sinus syndrome, A-V nodal disease, and enhancement of the action of other cardiodepressant drugs. Their use is generally contraindicated in obstruc-tive conditions (e.g., aortic stenosis). No consistent or significant changes in lipid and glucose levels have been reported with chronic therapy. Non–sustained release formulations of nifedipine are contraindicated in hyper-tension because of sympathetic rebound that may ag-gravate existing left ventricular dysfunction.


Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Modern Pharmacology with Clinical Applications: Calcium Channel Blockers : Calcium Channel Blockers: Toxicity |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.